Colleagues, I am writing to give you a mid-year progress report for the Journal of Investigative Medicine (JIM).
In the environment of ongoing COVID-19 challenges, with increasing clinical and/or administrative responsibilities for all researchers, JIM has continued to sustain the growth we witnessed in 2020. Here are some highlights for 2021 when compared with the data from June 2020.
There has been a steady increase in submissions over the past 2 years. Through June 2021, submissions have grown 50% versus the same time period in 2020 (figure 1).
The editorial team continues to work to improve the quality of JIM submissions, as evidenced by a decreased acceptance rate for all papers of 25% (figure 2).
Web traffic has been …
Log in using your username and password
Log in through your institution
PURCHASE SHORT TERM ACCESS
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
